Citations (40)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Sadegh Ghaderi, Farzad Fatehi, Sanjay Kalra & Seyed Amir Hossein Batouli. (2023) MRI biomarkers for memory-related impairment in amyotrophic lateral sclerosis: a systematic review. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 24:7-8, pages 572-588.
Read now
Read now
Alex Sherman, Robert Bowser, Daniela Grasso, Breen Power, Carol Milligan, Matthew Jaffa & Merit Cudkowicz. (2011) Proposed BioRepository platform solution for the ALS research community. Amyotrophic Lateral Sclerosis 12:1, pages 11-16.
Read now
Read now
Hayrettin Tumani, Charlotte Teunissen, Sigurd Süssmuth, Markus Otto, Albert C Ludolph & Johannes Brettschneider. (2008) Cerebrospinal fluid biomarkers of neurodegeneration in chronic neurological diseases. Expert Review of Molecular Diagnostics 8:4, pages 479-494.
Read now
Read now
Henrik Ryberg & Robert Bowser. (2008) Protein biomarkers for amyotrophic lateral sclerosis. Expert Review of Proteomics 5:2, pages 249-262.
Read now
Read now
Richard S. Bedlack, Daniel Pastula, Emily Welsh, Darlene Pulley & Merit E. Cudkowicz. (2008) Scrutinizing enrollment in ALS clinical trials: Room for improvement?. Amyotrophic Lateral Sclerosis 9:5, pages 257-265.
Read now
Read now
Angelina S. Palma, Mamede De Carvalho, Nicolas Grammel, Susana Pinto, Nuno Barata, Harald S. Conradt & Júlia Costa. (2008) Proteomic analysis of plasma from Portuguese patients with familial amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis 9:6, pages 339-349.
Read now
Read now
Srikanth Ranganathan, Georgina C. B. Nicholl, Sarah Henry, Fran Lutka, Ramasri Sathanoori, David Lacomis & Robert Bowser. (2007) Comparative proteomic profiling of cerebrospinal fluid between living and post mortem ALS and control subjects. Amyotrophic Lateral Sclerosis 8:6, pages 373-379.
Read now
Read now
Articles from other publishers (33)
Giovanna Morello, Salvatore Salomone, Velia D’Agata, Francesca Luisa Conforti & Sebastiano Cavallaro. (2020) From Multi-Omics Approaches to Precision Medicine in Amyotrophic Lateral Sclerosis. Frontiers in Neuroscience 14.
Crossref
Crossref
Lynne Hughes, Marie Trad, Stacey Boyer, Deborah Lee & Wei Yin. 2020. Drug Discovery and Evaluation: Methods in Clinical Pharmacology. Drug Discovery and Evaluation: Methods in Clinical Pharmacology
81
94
.
Lynne Hughes, Marie Trad, Stacey Boyer, Deborah Lee & Wei Yin. 2018. Drug Discovery and Evaluation: Methods in Clinical Pharmacology. Drug Discovery and Evaluation: Methods in Clinical Pharmacology
1
14
.
Les Halpin, Julian Savulescu, Kevin Talbot, Martin Turner & Paul Talman. (2015) Improving access to medicines: empowering patients in the quest to improve treatment for rare lethal diseases. Journal of Medical Ethics 41:12, pages 987-989.
Crossref
Crossref
Emily F. Mendez & Rita Sattler. (2015) Biomarker development for C9orf72 repeat expansion in ALS. Brain Research 1607, pages 26-35.
Crossref
Crossref
Ai-hua Zhang, Hui Sun & Xi-jun Wang. (2013) Recent advances in metabolomics in neurological disease, and future perspectives. Analytical and Bioanalytical Chemistry 405:25, pages 8143-8150.
Crossref
Crossref
Gaurav Verma, John H. Woo, Sanjeev Chawla, Sumei Wang, Sulaiman Sheriff, Lauren B. Elman, Leo F. McCluskey, Murray Grossman, Elias R. Melhem, Andrew A. Maudsley & Harish Poptani. (2013) Whole-Brain Analysis of Amyotrophic Lateral Sclerosis by Using Echo-Planar Spectroscopic Imaging. Radiology 267:3, pages 851-857.
Crossref
Crossref
Justin Y. Kwan, Avner Meoded, Laura E. Danielian, Tianxia Wu & Mary Kay Floeter. (2013) Structural imaging differences and longitudinal changes in primary lateral sclerosis and amyotrophic lateral sclerosis. NeuroImage: Clinical 2, pages 151-160.
Crossref
Crossref
Syuichi Tetsuka, Mitsuya Morita, Kunihiko Ikeguchi & Imaharu Nakano. (2013) Creatinine/cystatin C ratio as a surrogate marker of residual muscle mass in amyotrophic lateral sclerosis. Neurology and Clinical Neuroscience 1:1, pages 32-37.
Crossref
Crossref
Jonathan D. Glass. (2012) New drugs for ALS: How do we get there?. Experimental Neurology 233:1, pages 112-117.
Crossref
Crossref
Doreen Jia Yi Ng, Kishore Kumar Pasikanti & Eric Chun Yong Chan. (2010) Trend analysis of metabonomics and systematic review of metabonomics-derived cancer marker metabolites. Metabolomics 7:2, pages 155-178.
Crossref
Crossref
Lisa Staunton, Harald Jockusch & Kay Ohlendieck. (2011) Proteomic analysis of muscle affected by motor neuron degeneration: The wobbler mouse model of amyotrophic lateral sclerosis. Biochemical and Biophysical Research Communications 406:4, pages 595-600.
Crossref
Crossref
Mario Rafael Pagani, Laura Elisabeth Gonzalez & Osvaldo Daniel Uchitel. (2011) Autoimmunity in Amyotrophic Lateral Sclerosis: Past and Present. Neurology Research International 2011, pages 1-11.
Crossref
Crossref
Meghan E. Wilson, Imene Boumaza, David Lacomis & Robert Bowser. (2010) Cystatin C: A Candidate Biomarker for Amyotrophic Lateral Sclerosis. PLoS ONE 5:12, pages e15133.
Crossref
Crossref
Jian-Ying Zhou, Leila Afjehi-Sadat, Seneshaw Asress, Duc M. Duong, Merit Cudkowicz, Jonathan D. Glass & Junmin Peng. (2010) Galectin-3 Is a Candidate Biomarker for Amyotrophic Lateral Sclerosis: Discovery by a Proteomics Approach. Journal of Proteome Research 9:10, pages 5133-5141.
Crossref
Crossref
Ru Wei, Guodong Li & Albert B. Seymour. (2010) High-Throughput and Multiplexed LC/MS/MRM Method for Targeted Metabolomics. Analytical Chemistry 82:13, pages 5527-5533.
Crossref
Crossref
Ryan M. Mitchell, Zachary Simmons, John L. Beard, Helen E. Stephens & James R. Connor. (2010) Plasma biomarkers associated with ALS and their relationship to iron homeostasis. Muscle & Nerve 42:1, pages 95-103.
Crossref
Crossref
Kevin Boylan, Cui Yang, Julia Crook, Karen Overstreet, Michael Heckman, Yong Wang, David Borchelt & Gerry Shaw. (2009) Immunoreactivity of the phosphorylated axonal neurofilament H subunit (pNF-H) in blood of ALS model rodents and ALS patients: evaluation of blood pNF-H as a potential ALS biomarker. Journal of Neurochemistry 111:5, pages 1182-1191.
Crossref
Crossref
Steven J. Shook & Erik P. Pioro. (2009) Racing against the clock: Recognizing, differentiating, diagnosing, and referring the amyotrophic lateral sclerosis patient. Annals of Neurology 65:S1, pages S10-S16.
Crossref
Crossref
David C. Dorman, Melanie F. Struve, Amy Norris & Alan J. Higgins. (2008) Metabolomic Analyses of Body Fluids after Subchronic Manganese Inhalation in Rhesus Monkeys. Toxicological Sciences 106:1, pages 46-54.
Crossref
Crossref
Johannes Brettschneider, Helga Mogel, Vera Lehmensiek, Tino Ahlert, Sigurd Süssmuth, Albert C. Ludolph & Hayrettin Tumani. (2008) Proteome Analysis of Cerebrospinal Fluid in Amyotrophic Lateral Sclerosis (ALS). Neurochemical Research 33:11, pages 2358-2363.
Crossref
Crossref
Jing Zhang, C. Dirk Keene, Catherine Pan, Kathleen S. Montine & Thomas J. Montine. (2008) Proteomics of Human Neurodegenerative Diseases. Journal of Neuropathology & Experimental Neurology 67:10, pages 923-932.
Crossref
Crossref
Jeremy M. Shefner. (2008) Designing Clinical Trials in Amyotrophic Lateral Sclerosis. Physical Medicine and Rehabilitation Clinics of North America 19:3, pages 495-508.
Crossref
Crossref
H. Laaksovirta, S. Soinila, V. Hukkanen, M. Röyttä & M. Soilu-Hänninen. (2008) Serum level of CNTF is elevated in patients with amyotrophic lateral sclerosis and correlates with site of disease onset. European Journal of Neurology 15:4, pages 355-359.
Crossref
Crossref
Fabiana Perocchi, Eugenio Mancera & Lars M. Steinmetz. (2008) Systematic screens for human disease genes, from yeast to human and back. Mol. BioSyst. 4:1, pages 18-29.
Crossref
Crossref
Martin H. Maurer. (2008) Proteomics of brain extracellular fluid (ECF) and cerebrospinal fluid (CSF). Mass Spectrometry Reviews, pages n/a-n/a.
Crossref
Crossref
Katrina Gwinn, Roderick A. Corriveau, Hiroshi Mitsumoto, Kate Bednarz, Robert H. Brown, Merit Cudkowicz, Paul H. Gordon, John Hardy, Edward J. Kasarskis, Petra Kaufmann, Robert Miller, Eric Sorenson, Rup Tandan, Bryan J. Traynor, Josefina Nash, Alex Sherman, Matthew D. Mailman, James Ostell, Lucie Bruijn, Valerie Cwik, Stephen S. Rich, Andrew Singleton, Larry Refolo, Jaime Andrews, Ran Zhang, Robin Conwit & Margaret A. Keller. (2007) Amyotrophic Lateral Sclerosis: An Emerging Era of Collaborative Gene Discovery. PLoS ONE 2:12, pages e1254.
Crossref
Crossref
L. V. Brylev, A. A. Yakovlev, M. V. Onufriev, M. N. Zakharova, I. A. Zavalishin & N. V. Gulyaeva. (2007) Calpain-like and lactate dehydrogenase activities in the cerebrospinal fluid of patients with amyotrophic lateral sclerosis. Neurochemical Journal 1:4, pages 326-333.
Crossref
Crossref
Markus Wiksten, Antti Väänänen & Päivi Liesi. (2007) Selective overexpression of γ1 laminin in astrocytes in amyotrophic lateral sclerosis indicates an involvement in ALS pathology. Journal of Neuroscience Research 85:9, pages 2045-2058.
Crossref
Crossref
JD Mitchell & GD Borasio. (2007) Amyotrophic lateral sclerosis. The Lancet 369:9578, pages 2031-2041.
Crossref
Crossref
Carsten W. Lederer & Niovi Santama. (2007) Amyotrophic lateral sclerosis – The tools of the trait. Biotechnology Journal 2:5, pages 608-621.
Crossref
Crossref
In-Soo JooDong-Hoon HwangJung-Im SeokSang-Kun ShinSeung-Up Kim. (2007) Oral Administration of Memantine Prolongs Survival in a Transgenic Mouse Model of Amyotrophic Lateral Sclerosis. Journal of Clinical Neurology 3:4, pages 181.
Crossref
Crossref
Christi Kolarcik & Robert Bowser. (2012) Plasma and Cerebrospinal Fluid-Based Protein Biomarkers for Motor Neuron Disease. Molecular Diagnosis & Therapy 10:5, pages 281-292.
Crossref
Crossref